ArticleAnnals of the rheumatic diseases2016

Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.

Zhuang Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.